fda announcement semaglutide As of February 21, 2025, the updated its drug shortage list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A The FDA Has Approved An

Areas of concern could include: Your healthcare provider may suggest medication (like iron supplements or TSH replacement therapy) to treat any underlying problems that are causing these body temperature changes

Why it matters Strengthens the cardiometabolic positioning of GLP-1 receptor agonists and dual GIP/GLP-1 agonists

Anaesth Published Online Febr

Many women on calorie-restricted diets are vitamin D deficient, and calcium intake often drops with overall caloric intake

Effect of diabetes and insulin on the maximum capacity of the renal tubules to reabsorb glucose

It has long been assumed that the anti-diabetic benefits of metformin are due to its hepatic-mediated actions in human subjects and that other clinical benefits are secondary to its effects on glucose and lipid metabolism